Lunai Bioworks (LNAI) Share-based Compensation (2018 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Share-based Compensation of $168993.0 in Q1 2026, up 31.19% quarter-over-quarter from $128819.0 in Q4 2025, and down 88.73% on a YoY basis from $1.5 million in Q1 2025.
Lunai Bioworks (LNAI) Share-based Compensation (2018 - 2026) Analysis & Trends
Lunai Bioworks' Share-based Compensation history runs 8 years deep, the most recent figure standing at $168993.0 for Q1 2026.
- In Q1 2026, Share-based Compensation fell 88.73% year-over-year to $168993.0; the TTM figure through Mar 2026 stood at $2.0 million (down 53.75% YoY), while the FY2018 annual figure was $112837.0, changed N/A from the prior year.
- Share-based Compensation was $168993.0 for Q1 2026 at Lunai Bioworks, up from $128819.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $1.9 million in Q1 2024 to a low of $128819.0 in Q4 2025.
- Historically, Share-based Compensation has averaged $748806.7 across 4 years, with a median of $558631.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Share-based Compensation fell 19.47% in 2025, then plunged 88.73% in 2026.
- A 4-year view of Share-based Compensation shows it stood at $999228.0 in 2023, then sank by 44.09% to $558631.0 in 2024, then sank by 76.94% to $128819.0 in 2025, then surged by 31.19% to $168993.0 in 2026.
- The last three Share-based Compensation figures came in at $168993.0 (Q1 2026), $128819.0 (Q4 2025), and $181312.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26.47 Mn |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | 168,993.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 168,993.00 |
| Mar 31, 2026 | 168,993.00 |
| Dec 31, 2025 | 128,819.00 |
| Dec 31, 2025 | 128,819.00 |
| Sep 30, 2025 | 181,312.00 |
| Sep 30, 2025 | 181,312.00 |
| Mar 31, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 558,631.00 |
| Dec 31, 2024 | 558,631.00 |
| Sep 30, 2024 | 357,648.00 |
| Sep 30, 2024 | 357,648.00 |
| Mar 31, 2024 | 1.86 Mn |
| Mar 31, 2024 | 1.86 Mn |
| Dec 31, 2023 | 999,228.00 |
| Dec 31, 2023 | 999,228.00 |
| Sep 30, 2023 | 983,829.00 |
| Sep 30, 2023 | 983,829.00 |
| Mar 31, 2021 | 499,428.00 |
| Mar 31, 2021 | 499,428.00 |